Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma

Table 5

Comparison of diagnostic performance among the NMP22 BladderChek test, urine cytology, and the combination of two tests for the diagnosis of primary urothelial carcinoma based on clinical diagnosis.

Number of patients	Cytology		NMP22		value
	Agreement	Disagreement	Agreement	Disagreement
NMP22					0.017
Agreement	50	5
Disagreement	17	18
Combination					1.000^#; 0.001^&
Agreement	61	5	55	11
Disagreement	6	18	0	24

Note: the McNemar test was performed to compare the diagnostic values among the NMP22 BladderChek test, urine cytology, and the combination of two tests; NMP22 vs. cytology; ^#combination vs. cytology; ^&combination vs. NMP22.